Evaluation of protective effect of Aegle marmelos Corr. in an animal model of chronic fatigue syndrome

Indian Journal of Pharmacology

Volumn 44, Issue 3, 2012, Pages 351-356

  Lalremruta, Vanphawng ^a   Prasanna, Gurunath S ^a  

^a A Constituent Unit of KLE Academy of Higher Education Research   (India)

Author keywords

Aegle marmelos; chronic fatigue syndrome; duration of immobility; lipid peroxidation

Indexed keywords

AEGLE MARMELOS EXTRACT; BIOLOGICAL MARKER; CATALASE; IMIPRAMINE; SUPEROXIDE DISMUTASE;

AEGLE MARMELOS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN HOMOGENATE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; FEMALE; FORCED SWIMMING TEST; IMMOBILIZATION; LIPID OXIDATION; LOCOMOTION; MAZE TEST; NONHUMAN; OXIDATIVE STRESS; PLANT LEAF; RAT; TREATMENT OUTCOME;

EID: 84861844835     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.96316     Document Type: Article

References (32)

1. Fakuda K, Straus SE, Hickle I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue syndrome study group. Ann Intern Med 1994;121:953-9.
2. Afari N, Buchwald D. Chronic Fatigue Syndrome: A Review. Am J Psychiatry 2003;160:221-36.
3. Carruthers M, Jain AK, DeMeirleir KL, Peterson DL, Klimas NG. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols. J Chronic Fatigue Syndr 2003;11:7-97.
4. Pall ML. Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome. Med Hypotheses 2000;54:115-25.
5. Ross SR, Wang L. Erythrocyte damage in chronic fatigue syndrome. Arch Med Res 2007;38:92-8.
6. Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JF. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med 2005;39:584-9.
7. Richards RS, Roberts TK, McGregor NR. Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep 2000;5:35-41.
8. Maity P, Hansda D, Bandyopadhyay U, Mishra DK. Biological activities of crude extracts and chemical constituents of Bael. Indian J Exp Biol 2009;47:849-61.
9. Vijaya C, Ramanathan M, Suresh B. Lipid lowering activity of ethanolic extract of leaves of Aegle marmelos (Linn.) in hyperlipedemic model of wistar albino rats. Indian J Exp Biol 2009;47:182-5.
10. Prema P. Antibacterial activiy of selected medicinal plants. J Ecobiol 2004;16:333-7.
11. Premchanien M, Kosam N, Luanratana O, Jongsomboonkusos S, Ponipon N. Anti proliferative activity of Thai medicinal plant extracts on human breast adrenocarcinoma cell line. Fitoterapia 2004;75:375-7.
12. Chauhan A, Agarwal S, Kwhwaha S, Mutresa A. Suppression of fertility in nmale albino rats following the administration of 50% ethanolic extract of Aegle marmelos. Contraception 2007;76:474-81.
13. Arul V, Miyazaki S, Dhanjayan R. Studies on antiinflammatory, antipyretic and analgesic properties of leaves of Aegle marmelos Corr. J Ethnopharmacol 2005;96:159-63.
14. Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. 28th ed. Pune: Nirali Prakashan; 2008. p. 6.16-6.17.
15. OECD Enviornment, Health and safety publication, series on testing and assessment No.24, Guidance document on Acute oral toxicity testing, Enviornment Directorate, Organisation for Economic Co-operation and Development, Paris, 2001.
16. Lyle N, Sur T, Munshi S, Paul S, Chatterjee S, Bhattacharyya D. The role of antioxidant properties of Nardostachys jatamansi in alleviation of the symptoms of the chronic fatigue syndrome. Behav Brain Res 2009;202:285-90.
17. Kumar A, Garg R, Kumar P. Nitric oxide modulation mediates the protective role of trazodone in a mouse model of chronic fatigue syndrome. Pharmacol Rep 2008;60:664-72.
18. Kulkarni SK. Handbook of experimental pharmacology. New Delhi: Vallabh Prakashan; 2005. p. 135-7.
19. Kulkarni SK, Singh K, Bishnoi M. Elevated Zero Maze: A Paradigm to evaluate antianxiety effects of drugs. Methods Find Exp Clin Pharmacol 2007;29: 343-8.
20. Kumar A, Garg R. Protective effects of antidepressants against chronic fatigue syndrome-induced behavioral changes and biochemical alterations. Fundam Clin Pharmacol 2009;23:89-95.
21. Pomory CM. Color development time of the Lowry protein assay. Anal Biochem 2008;378:216-7.
22. Yazdanparast R, Bahramikia S, Ardestani A. Nasturtium officinale reduces oxidative stress and enhances antioxidant capacity in hyperchloresterolaemic rats. Chem Biol Interact 2008;172:176-84.
23. Sinha KA. Colorimetric assay of catalase. Anal Biochem 1972;47:389-94.
24. Kakker P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984;21:130-2.
25. Alan C, Logan ND, Wong C. Chronic fatigue syndrome: Oxidative stress and dietary modifications. Altern Med Rev 2001;6:450-9.
26. Kalenova LF, Sukhovei YG, Fisher TA. Specific and non-specific reactions of mouse immune system under the effect of short term exposure in warm and/or cold water. Bull Biol Med 2005;6:23-34.
27. Demitrack MA, Gold PW, Dale JK, Krahn DD. Plasma and cerebrospinal fluid monoaminemetabolism in patients with chronic fatigue syndrome: Preliminary findings. Biol Psychiatry 1992;32:1065-77.
28. Giorgio D, Hudson A, Jerjes M, Cleare W. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome. Psychol Med 2005;67:433-40.
29. Halliwell B, Chirico S. Lipid peroxidation: Its mechanism, measurement, and significance. Am J Clin Nutr 1993;57:15-25.
30. Murray KM, Granner DK, Mayes PA, Rodwell VW. Harper's Illustrated Biochemistry. 26th ed., chap. 11. McGraw-Hill Publication; 2003. p. 90-128.
31. Saltsman K, Berg JM, Tomaselli G. Biochemistry. 5th ed., chap. 18. WH Freeman and Company Publication; 2005. p. 748-9.
32. Hugh SB, Deacon RM, Rawlins JNP, Bannerman DM. Amygdala and ventral hippocampuscontribute differentially to mechanisms of fear and anxiety. Behav Neurosci 2004;118:63-78.